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Abstract 
 
The hexosamine biosynthesis pathway (HBP) serves as a sensor of excess nutrient bioavailability 
and has been implicated in the pathogenesis of type 2 diabetes. Previous study observed that 
hyperinsulinemic culturing conditions akin to those seen clinically activate the HBP provoking 
gains in plasma membrane (PM) cholesterol content in L6 myotubes and 3T3-L1 adipocytes. 
This, in turn, compromised the cortical filamentous actin (F-actin) structure necessary for the 
proper incorporation of the insulin sensitive glucose transporter GLUT4 into the membrane. The 
mechanism(s), however, by which HBP activation provokes PM cholesterol accrual, remains 
unclear. Here, the hypothesis that HBP engages a cholesterolgenic transcriptional response 
resulting in PM cholesterol accrual/toxicity was tested. In 3T3-L1 adipocytes, 
pathophysiologically relevant doses of hyperinsulinemia (0.25, 0.5, and 5 nM) resulted in a dose-
dependent gain in PM cholesterol as well as mRNA and protein levels of HMG-CoA reductase 
(HMGR), the rate limiting enzyme in cholesterol synthesis. Immunoprecipitation experiments 
demonstrated that hyperinsulinemia induced elevations in O-linked N-acetylglucosamine post-
translational modification of the cholesterolgenic transcription factor specificity protein 1 (Sp1). 
This modification was prevented in cells in which the HBP was inhibited. Chromatin 
immunoprecipitation demonstrated that hyperinsulinemia induced a ~4 fold increase in the 
affinity of Sp1 to the promoter region of HMGR, which was lost with HBP inhibition. Luciferase 
assays confirmed that this altered binding resulted in a ~50% increase in promoter activity of this 
cholesterolgenic gene. Hyperinsulinemia also augmented Sp1 binding to the promoter of the 
sterol response element binding protein gene, resulting in increased total and nuclear content of 
this factor. To further delineate the role of Sp1 in this process, a specific inhibitor, mithramycin 
(MTR), of Sp1 binding to DNA was employed. This inhibitor prevented against 
hyperinsulinemia-induced gains in HMGR and PM cholesterol as well as F-actin loss. 
Importantly, this treatment corrected the impaired insulin-stimulated GLUT4 translocation and 
glucose transport induced by hyperinsulinemia. These data suggest hyperinsulinemia-induced 
HBP activity provokes cholesterol synthesis and PM cholesterol accrual/F-actin loss that 
compromises GLUT4/glucose transport regulation by insulin. 
 
